This article is for Medical Students & Professionals
This is a Question & Answer revision article designed for medical students and professionals preparing for the PLAB, MRCP or USMLE examinations. They are based on actual questions from these examinations. You may find the Digestive Health articles more useful, or one of our many articles on Diseases & Conditions, Medical Syndromes, Health & Wellness or Home Remedies.
Mechanism of cytotoxic-induced hepatotoxicity
MCQ exam: clinical scenario
MCQ exam: answer
MCQ exam: explanation
Mechanism of cytotoxic-induced hepatotoxicity
Potential interactions between the liver and chemotherapy fall into two categories:- Direct chemotherapy-induced hepatotoxicity.
- Potentiation of preexisting liver disease, especially viral hepatitis. Altered hepatic drug metabolism due to underlying liver disease can result in higher or more persistent drug levels, thereby causing increased systemic toxicity (particularly myelosuppression) or worsening of liver function because of chemotherapy-induced hepatotoxicity.
MCQ exam: clinical scenario
Hepatic toxicities is a known side effect of several cytotoxic drugs.Which of the following cytotoxic drugs is most likely to lead to cirrhosis?
a) Anthracyclines
b) 5-fluorouracil
c) Taxoids
d) Cyclopentenyl cytosine
e) Methotraxate
MCQ exam: answer
The correct answer is E.MCQ exam: explanation
Methotrexate induced cirrhosis has resulted in liver transplantation in a number of patients. Despite the concerns spanning half of a century for the potential risk for hepatic cirrhosis with the use of methotrexate in nonmalignant diseases such as psoriasis, later studies in patients with rheumatoid arthritis alleviated some of the fears. However, “word of caution” still requires very close patient monitoring, in particular in those with concurrent obesity and diabetes.Reference(s)
1). S C Gilbert, G Klintmalm, A Menter, A Silverman: Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent. Arch Intern Med. 1990 Apr;150(4):889-91. PMID: 2327848
2). Alla Grigoria, Christopher B. O'Brien: Hepatotoxicity Secondary to Chemotherapy. J Clin Transl Hepatol. 2014 Jun; 2(2): 95–102. Published online 2014 Jun 15. doi:10.14218/JCTH.2014.00011
3). UpToDate: Chemotherapy hepatotoxicity and dose modification in patients with liver disease: Conventional cytotoxic agents. Available online: https://www.uptodate.com/contents/chemotherapy-hepatotoxicity-and-dose-modification-in-patients-with-liver-disease-conventional-cytotoxic-agents
No comments:
Post a Comment
Got something to say? We appreciate your comments: